On Friday, in the course of current trade, Shares of Best Buy Co., Inc. (NYSE:BBY), dropped -2.14%, and is now trading at $34.36.
Best Buy, declared results for the first quarter (“Q1 FY16”) ended May 2, 2015 as contrast to the first quarter ended May 3, 2014. During the quarter, as declared on March 28, 2015, the company merged the Future Shop and Best Buy brands in Canada under the Best Buy brand. This consolidation is predictable to have a material impact on all of the Canadian retail stores and the website on a year-over-year basis. As such, all Canadian revenue has been removed from the comparable sales base and International no longer has a comparable metric. Therefore, Enterprise comparable sales will be equal to Domestic comparable sales until International revenue is again comparable on a year-over-year basis.
Best Buy Co., Inc. operates as a retailer of technology products, services, and solutions in the United States and internationally. Its stores offer consumer electronics comprising primarily of television and home theaters; digital cameras and camcorders; DVD and Blu-ray players; portable electronics, such as MP3 devices, headphones and speakers, car stereo, navigation and satellite radio; and related accessories.
During an Afternoon trade, Shares of Neostem, Inc. (NASDAQ:NBS), dipped -5.42%, and is now trading at $2.79.
NeoStem, declared Thursday that it will receive one of the largest research grants of its kind to support its pioneering treatment for patients with stage III recurrent or stage IV metastatic melanoma, a potentially breakthrough approach that teaches the immune system which cells to attack and kill.
The $17.7 million grant from the California Institute for Regenerative Medicine (CIRM), a distinguished and independent scientific body, is a noteworthy endorsement of the potential for NeoStem’s novel approach for treating metastatic melanoma, the most deadly form of skin cancer. The sheer scope of the award has important implications as it is predictable to fund a noteworthy portion of the pivotal Phase 3 clinical trial investigating a personalized cancer treatment and presently enrolling patients at centers across the United States.
Trial results to date support the expectation that this novel approach will improve overall survival. In a Phase 2 randomized, controlled trial of the therapy, results showed a 72 percent two-year survival rate, contrast with 31 percent in the control group.
NeoStem’s belief is that if the Phase 3 trial is successful, and the therapy is then approved by the FDA, it could be a breakthrough in the treatment of metastatic melanoma patients and accessible as early as 2018.
NeoStem, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States. It is developing NBS20, a targeted cancer immunotherapy product that is in Phase III clinical trials for the treatment of metastatic melanoma; NBS10, a ischemic repair product that is in Phase II clinical trial to preserve heart muscle function following an acute myocardial infarction; and NBS03D, an immune modulation product that is in Phase II clinical trials for the treatment of type 1 diabetes.
Shares of The Blackstone Group L.P. (NYSE:BX), during its Friday’s current trading session fell -0.69%, and is now trading at $43.27.
The Blackstone Group, declared that Jon Gray, Global Head of Real Estate at Blackstone, will present at the Morgan Stanley Financials Conference in New York on Tuesday, June 9th, 2015 at about 3:35 p.m. ET.
The Blackstone Group L.P. is a publicly owned investment manager. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations.
Finally, Dominion Resources, Inc. (NYSE:D), lost -0.31% Friday.
Dominion Resources, has declared that, subject to the planned close of recent sale of about $200 million of its common stock through a registered underwritten public offering to UBS Securities LLC, it has accomplished its presently planned market issuances of equity for calendar year 2015. With recent offering and the formerly accomplished “at the market” issuances of common stock during this year of about $300 million, the company has accomplished $500 million in market issuances of new equity in 2015. The company has no current plans to issue to the market any additional shares of its common stock or other equity-linked securities this year.
Dominion Resources, Inc. produces and transports energy in the United States. The company operates through three segments: Dominion Virginia Power (DVP), Dominion Generation, and Dominion Energy.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
